Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 167

Results For "RNA"

2243 News Found

NAMSA to acquire European-based Medanex clinic
Biotech | March 30, 2022

NAMSA to acquire European-based Medanex clinic

World-leading companies, as well as small innovative research groups, regularly partner with Medanex for their outstanding cardiovascular services and timely, efficacious study outcomes.


Metropolis recognises medical students with scholarship grants and awards
Diagnostic Center | March 28, 2022

Metropolis recognises medical students with scholarship grants and awards

Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India


Vela Diagnostics launches NGS-based pan-cancer panels
Medical Device | March 28, 2022

Vela Diagnostics launches NGS-based pan-cancer panels

Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options


Tata Capital Healthcare Fund II raises Rs 955 crore
News | March 28, 2022

Tata Capital Healthcare Fund II raises Rs 955 crore

The fund will take equity positions in India-focused healthcare and life sciences-related companies


New spesolimab data show promising results in patients with generalised pustular psoriasis flares
Biotech | March 28, 2022

New spesolimab data show promising results in patients with generalised pustular psoriasis flares

Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status


NMPA approves Hansizhuang, its first monoclonal antibody
Drug Approval | March 27, 2022

NMPA approves Hansizhuang, its first monoclonal antibody

It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry


USFDA approves Janssen’s injectable regimen for HIV
Drug Approval | March 25, 2022

USFDA approves Janssen’s injectable regimen for HIV

Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV


Parata Systems earns HITRUST certification
News | March 25, 2022

Parata Systems earns HITRUST certification

It recognizes the company's commitment to safeguarding sensitive data, protecting patient information


Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting
News | March 25, 2022

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting

Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment


Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India